INT327999

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.02
First Reported 2010
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 4
Disease Relevance 3.72
Pain Relevance 0.53

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

plasma membrane (FPR2, FPR3) signal transducer activity (FPR2, FPR3) signal transduction (FPR3)
cell adhesion (FPR2)
Anatomy Link Frequency
monocytes 2
neutrophils 2
FPR2 (Homo sapiens)
FPR3 (Homo sapiens)
Pain Link Frequency Relevance Heat
Kinase C 16 89.28 High High
cytokine 4 5.00 Very Low Very Low Very Low
Neuritis 4 5.00 Very Low Very Low Very Low
Peripheral nervous system 4 5.00 Very Low Very Low Very Low
Inflammation 4 5.00 Very Low Very Low Very Low
Multiple sclerosis 4 5.00 Very Low Very Low Very Low
Demyelination 4 5.00 Very Low Very Low Very Low
Crohn's disease 4 5.00 Very Low Very Low Very Low
Arthritis 4 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Syndrome 104 97.44 Very High Very High Very High
Disease 40 88.76 High High
Recurrence 44 86.00 High High
Urological Neuroanatomy 36 73.92 Quite High
Autoimmune Disease 36 33.36 Quite Low
Infection 20 5.00 Very Low Very Low Very Low
Demyelinating Disease 16 5.00 Very Low Very Low Very Low
Neutrophil Disorders 16 5.00 Very Low Very Low Very Low
Cytomegalovirus Infection 12 5.00 Very Low Very Low Very Low
Herpes Zoster 12 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
The peptides fMLF and WKYMVM activates NADPH oxidase via formyl peptide receptors (FPRs), which are transmembrane G-protein coupled receptors present in monocytes and neutrophils. fMLF interacts with FPR1, whereas WKYMVM binds to FPR2 and FPR3 [22].
FPR2 Binding (binds) of FPR3 in monocytes
1) Confidence 0.02 Published 2010 Journal J Inflamm (Lond) Section Body Doc Link PMC2924308 Disease Relevance 0.93 Pain Relevance 0.13
The peptides fMLF and WKYMVM activates NADPH oxidase via formyl peptide receptors (FPRs), which are transmembrane G-protein coupled receptors present in monocytes and neutrophils. fMLF interacts with FPR1, whereas WKYMVM binds to FPR2 and FPR3 [22].
FPR2 Binding (binds) of FPR3 in monocytes
2) Confidence 0.02 Published 2010 Journal J Inflamm (Lond) Section Body Doc Link PMC2924308 Disease Relevance 0.93 Pain Relevance 0.13
The peptides fMLF and WKYMVM activates NADPH oxidase via formyl peptide receptors (FPRs), which are transmembrane G-protein coupled receptors present in monocytes and neutrophils. fMLF interacts with FPR1, whereas WKYMVM binds to FPR2 and FPR3 [22].
FPR2 Binding (binds) of FPR3 in neutrophils
3) Confidence 0.01 Published 2010 Journal J Inflamm (Lond) Section Body Doc Link PMC2924308 Disease Relevance 0.93 Pain Relevance 0.13
The peptides fMLF and WKYMVM activates NADPH oxidase via formyl peptide receptors (FPRs), which are transmembrane G-protein coupled receptors present in monocytes and neutrophils. fMLF interacts with FPR1, whereas WKYMVM binds to FPR2 and FPR3 [22].
FPR2 Binding (binds) of FPR3 in neutrophils
4) Confidence 0.01 Published 2010 Journal J Inflamm (Lond) Section Body Doc Link PMC2924308 Disease Relevance 0.93 Pain Relevance 0.13

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox